MAPK14 and craniosynostosis: Given the predominance of Prrx1+ cells within the cranial suture mesenchymal cell population and their significant overlap with other suture stem cell populations, this study employed Prrx1+ cell-specific Mapk14 cKO to prevent SPC senescence and ameliorate craniosynostosis.